Monahan Joseph (CIK 0001861790)

Latest company ownership

ACRS - Aclaris Therapeutics, Inc.
Role: Chief Scientific Officer
Shares held
193
Last filed at
Mar 5, 2024
Confidence Score
49.9
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 1, 2025 Mar 4, 2025 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 42.5 -27,258 -9.30% ✗ $54.2K
Feb 1, 2025 Feb 4, 2025 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 46.3 -11,317 -4.65% ✗ $28.1K
Mar 1, 2024 Mar 5, 2024 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 46.3 -21,283 -3.83% ✗ $26.4K
Feb 1, 2024 Feb 5, 2024 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 47.5 -2,583 -1.88% ✗ $3.1K
Oct 23, 2023 Oct 25, 2023 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 41.3 -6,000 -4.41% ✓ $30.5K
Aug 21, 2023 Aug 22, 2023 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 41.3 -6,000 -4.23% ✓ $43.9K
Jun 20, 2023 Jun 22, 2023 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 37.5 -6,000 -4.06% ✓ $61.7K
Mar 1, 2023 Mar 3, 2023 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 40.0 -30,837 -9.34% ✗ $385.6K
Feb 15, 2023 Feb 17, 2023 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 32.5 -5,000 -5.18% ✓ $65.3K
Dec 15, 2022 Dec 16, 2022 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 37.5 -5,000 -4.92% ✓ $79.4K
Oct 17, 2022 Oct 19, 2022 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 37.5 -5,000 -4.69% ✓ $79.9K
Apr 18, 2022 Apr 20, 2022 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 12.5 -30,000 -21.97% ✓ $488.3K
Mar 10, 2022 Mar 14, 2022 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 40.0 -27,165 -16.59% ✗ $426.8K
Feb 9, 2022 Feb 11, 2022 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 52.5 -383 -0.44% ✗ $4.9K
Sep 1, 2021 Sep 2, 2021 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 46.3 -1,041 -1.18% ✗ $17.9K
Jun 1, 2021 Jun 2, 2021 Aclaris Therapeutics, Inc. Chief Scientific Officer Sell 40.0 -21,790 -20.30% ✗ $471.4K